Shares of Vertex Pharmaceuticals Inc. VRTX rallied 1.82% to $480.33 Thursday, on what proved to be an all-around grim trading ...
Barchart on MSN10h
Are Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?With a market cap of $118.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology leader specializing ...
AlgoTherapeutix blames a “strong placebo effect” for the mid-stage failure for its pain gel ATX01, but the company still ...
At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown ...
Vertex Pharmaceuticals (VRTX) stock gets an upgrade from Canaccord Genuity after its Q4 2024 results on Tuesday, Read more here.
Stocks are marking daily gains, but it's nothing to write home about as investors await an update on tariffs while readying ...
The last few weekends have been roiled by headlines. Here's why we took a different direction on this medical stock this week ...
If you’re looking to dramatically change a room but don’t want to spend a lot of money, time, or even be especially committed to the results, consider removable wallpaper — specifically the ...
Vertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company known for its cystic fibrosis (CF) treatments, is at a critical juncture as it seeks to diversify its portfolio and maintain its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback